| |
The American journal of psychiatry, Vol. 166, No. 5. (May 2009), pp. 557-566.
|
| |
The New England journal of medicine, Vol. 359, No. 26. (25 December 2008), pp. 2753-2766.
by John T. Walkup, Anne Marie M. Albano, John Piacentini, et al.Boris Birmaher, Scott N. Compton, Joel T. Sherrill, Golda S. Ginsburg, Moira A. Rynn, James McCracken, Bruce Waslick, Satish Iyengar, John S. March, Philip C. Kendall
|
| |
International clinical psychopharmacology, Vol. 22, No. 6. (November 2007), pp. 338-347.
|
| |
CNS spectrums, Vol. 13, No. 5. (May 2008), pp. 415-422.
|
| |
The New England journal of medicine, Vol. 358, No. 20. (15 May 2008), pp. 2185-2186.
|
| |
Digestive diseases and sciences, Vol. 48, No. 5. (May 2003), pp. 939-944.
|
| |
Drug safety : an international journal of medical toxicology and drug experience, Vol. 31, No. 4. (2008), pp. 345-354.
|
| |
Am J Psychiatry, Vol. 165, No. 3. (March 2008), pp. 342-351.
by M. Fava, A. J. Rush, J. E. Alpert, et al.G. K. Balasubramani, S. R. Wisniewski, C. N. Carmin, M. M. Biggs, S. Zisook, A. Leuchter, R. Howland, D. Warden, M. H. Trivedi
|
| |
Drug Saf, Vol. 31, No. 2. (2008), pp. 159-168.
|
| |
Psychosomatics, Vol. 49, No. 1. (b 2008), pp. 84-85.
|
| |
The British Journal of Psychiatry, Vol. 192, No. 2. (1 February 2008), pp. 124-129.
|
| |
The New England journal of medicine, Vol. 358, No. 3. (17 January 2008), pp. 252-260.
|
| |
Arch Intern Med, Vol. 168, No. 2. (28 January 2008), pp. 180-185.
|
| |
Arch Gen Psychiatry, Vol. 65, No. 1. (1 January 2008), pp. 38-46.
by David A. Barton, Murray D. Esler, Tye Dawood, et al.Elisabeth A. Lambert, Deepak Haikerwal, Celia Brenchley, Florentia Socratous, Jacqueline Hastings, Ling Guo, Glen Wiesner, David M. Kaye, Richard Bayles, Markus P. Schlaich, Gavin W. Lambert
|
| |
Depress Anxiety, Vol. 14, No. 1. (2001), pp. 19-28.
|
| |
Clin Ther, Vol. 29, No. 5. (May 2007), pp. 918-926.
|
| |
Am J Psychiatry, Vol. 164, No. 9. (September 2007), pp. 1379-1384.
|
| |
Clin Pharmacol Ther (11 July 2007)
|
| |
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2684-2692.
|
| |
N Engl J Med, Vol. 356, No. 26. (28 June 2007), pp. 2675-2683.
|
| |
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1240-1245.
|
| |
Arch Intern Med, Vol. 167, No. 12. (25 June 2007), pp. 1246-1251.
|
| |
Arch Gen Psychiatry, Vol. 64, No. 6. (June 2007), pp. 679-688.
by R. Cooper-Kazaz, J. T. Apter, R. Cohen, et al.L. Karagichev, S. Muhammed-Moussa, D. Grupper, T. Drori, M. E. Newman, H. A. Sackeim, B. Glaser, B. Lerer
|
| |
JAMA, Vol. 287, No. 14. (10 April 2002), pp. 1840-1847.
|
| |
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 2. (April 2007), pp. 127-140.
|
| |
Hearing Research In Pharmacological Strategies for Prevention and Treatment of Hearing Loss and Tinnitus, Vol. 226, No. 1-2. (April 2007), pp. 221-231.
|
| |
Psychopharmacol Bull, Vol. 36 Suppl 2 (2002), pp. 123-132.
|
| |
Am J Psychiatry, Vol. 164, No. 5. (1 May 2007), pp. 768-777.
|
| |
Biomedecine & Pharmacotherapy, Vol. 60, No. 7. (August 2006), pp. 318-322.
|
| |
Pharmacoepidemiol Drug Saf, Vol. 15, No. 10. (October 2006), pp. 719-725.
|
| |
J Drugs Dermatol, Vol. 5, No. 10. (c 2006), pp. 1012-1014.
|
| |
J Am Acad Dermatol, Vol. 56, No. 5. (May 2007), pp. 848-853.
|
| |
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, No. 1. (February 2007), pp. 17-29.
|
| |
Br J Pharmacol, Vol. 147 Suppl 1 (January 2006)
|
| |
N Engl J Med, Vol. 356, No. 17. (26 April 2007), pp. 1711-1722.
by Gary S. Sachs, Andrew A. Nierenberg, Joseph R. Calabrese, et al.Lauren B. Marangell, Stephen R. Wisniewski, Laszlo Gyulai, Edward S. Friedman, Charles L. Bowden, Mark D. Fossey, Michael J. Ostacher, Terence A. Ketter, Jayendra Patel, Peter Hauser, Daniel Rapport, James M. Martinez, Michael H. Allen, David J. Miklowitz, Michael W. Otto, Ellen B. Dennehy, Michael E. Thase
|
| |
Arch Gen Psychiatry, Vol. 64, No. 3. (March 2007), pp. 327-337.
|
| |
Drug Safety, Vol. 30, No. 2. (2007), pp. 171-184.
|
| |
Drug Safety, Vol. 30, No. 2. (2007), pp. 107-121.
|
| |
CNS Drugs, Vol. 20, No. 3. (2006), pp. 187-198.
|
| |
CNS Drugs, Vol. 19, No. 7. (2005), pp. 623-633.
|
| |
N Engl J Med, Vol. 354, No. 6. (9 February 2006), pp. 579-587.
|
| |
Am J Psychiatry, Vol. 161, No. 6. (June 2004), pp. 1066-1078.
|
| |
Clin Pharmacol Ther, Vol. 81, No. 1. (2007), pp. 69-75.
|
| |
N Engl J Med, Vol. 352, No. 11. (17 March 2005), pp. 1112-1120.
|
| |
Curr Pharm Des, Vol. 11, No. 12. (2005), pp. 1475-1493.
|
| |
Nature Reviews Drug Discovery, Vol. 4, No. 9. (01 September 2005), pp. 764-774.
|
| |
Am J Psychiatry, Vol. 161, No. 5. (May 2004), pp. 826-835.
|
| |
Ann Pharmacother, Vol. 32, No. 6. (June 1998), pp. 692-698.
|
| |
Psychosomatics, Vol. 48, No. 1. (b 2007), pp. 1-9.
|
| |
Psychosom Med, Vol. 67 Suppl 1 (n 2005)
|